TPG Growth Leads USD125m Series C for India’s Stelis Biopharma

TPG Growth led a USD125m Series C for Stelis Biopharma, the biopharmaceutical unit of Mumbai-listed Strides Pharma Science, with participation from Route One, Think Investments and Mankekar Family. Strides also announced that Stelis closed a USD70m Series B, bringing total capital raised across the latest funding rounds to… Read More

Patria SPAC Files for USD250m IPO

Patria Acquisition, a SPAC formed by Patria Investimentos targeting Latin American companies, has filed to raise up to USD250m in an IPO on the Nasdaq. Read more… Read More

DILA Capital SPAC Files for USD50m IPO

DILA Capital Acquisition, a SPAC formed by DILA Capital targeting tech-enabled sectors in Latin America, has filed to raise up to USD50m in an IPO on the Nasdaq under the symbol DILAU. Read more… Read More



(default archive template)